Evidence map›Paper›PMID 42292494›Full record

ArticleFrontiers in immunology2026

A context-aware interpretive framework for lymphocyte immunophenotyping by flow cytometry.

Carlos Agustin Villegas-Valverde, Yendry Ventura-Carmenate

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Carlos Agustin Villegas-ValverdeAbu Dhabi Stem Cells Center, Abu Dhabi, United Arab Emirates.
Yendry Ventura-CarmenateAbu Dhabi Stem Cells Center and the United Arab Emirates University-College of Medicine, Abu Dhabi, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Flow cytometry-based immunophenotyping is a powerful tool in clinical and translational immunology; however, the interpretation of lymphocyte immunophenotype results remains incomplete, despite extensive methodological standardization. This challenge is particularly evident when phenotypically normal lymphocytes are quantified under non-physiological conditions, where numerical results are often interpreted using implicit and heterogeneous assumptions. Hypothesis: It is hypothesized that harmonization in flow cytometry-based lymphocyte immunophenotyping must extend beyond technical standardization and incorporate explicit, structured frameworks for biological and clinical interpretation for enumeration of phenotypically normal lymphocyte subsets. Implications: Five foundational guidelines are proposed for interpreting lymphocyte immunophenotypic enumeration: the non-equivalence of relative and absolute metrics, context-dependent relevance of immunophenotypic values, compartment-specific determination of meaning, analytical constraints imposed by assay architecture, and the impact of analytical variability on interpretative stability. By articulating principles that are already implicitly applied in expert practice, this framework complements existing technical guidelines and supports a more consistent, context-aware interpretation of lymphocyte immunophenotypes across diverse clinical and biological settings. Conclusion: By explicitly articulating principles that are typically implicit in expert practice, this framework complements existing technical guidelines and bridges the gap between technical and interpretative reproducibility. It provides a coherent structure for context-aware immunophenotypic interpretation and contributes to a shared conceptual language for the study of immunology and its clinical application.

Indexed as

Flow CytometryImmunophenotypingLymphocytesLymphocyte SubsetsHumansPractice Guidelines as TopicReproducibility of Resultsanalytical reproducibilityclinical immunologyflow cytometryinterpretive frameworklymphocyte immunophenotyping

Identifiers

PMID42292494
PMCPMC13260266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.